Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1. (European journal of endocrinology / European Federation of Endocrine Societies, 2008)

(untitled) - Hannan, F; Athanasou, N; Teh, J; Gibbons, C; Shine, B; Thakker, R